PL7-30054-13225 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-21
Registered in v-safe
2021-07-23
Dose 1 — Pfizer-BioNTech
2021-07-27
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Swelling, Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-07-28
Survey response — days 1–6 daily, dose 1
MedDRA: Influenza like illness, Nasopharyngitis, Sneezing — Feeling: Poor · Fever · Fatigue or tiredness

Free text: Cold flu like and sneezing

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-07-24
Survey response — 12 months, dose 1
MedDRA: COVID-19, Headache, Migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid 19, and headache migraine,

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-23	Pfizer-BioNTech	No

Free text

Release 9 — days 1–6 daily, dose 1

2021-07-28

Systemic reaction (other): Cold flu like and sneezing

Release 12 — 12 months, dose 1

2022-07-24

Symptoms: Covid 19, and headache migraine,

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Headache	·	·	✓
SD	Migraine	·	·	✓
SRO	Influenza like illness	✓	·	✓
SRO	Nasopharyngitis	✓	·	✓
SRO	Sneezing	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release